Furthermore, we find the role of ST6GAL1 in aggressive prostate cancer likely involves modification of the bone pre-metastatic niche towards bone resorption to promote the vicious cycle, the promotion of M2 like macrophages and the regulation of immunosuppressive sialoglycans. The gene discussed is ST6GAL1; the disease is prostate carcinoma.